Nevertheless, future studies focusing on understanding the molecular mechanisms that link mCa2+ uptake to effector function of CD4+ T-cells as well as mechanisms responsible for the differences between the two experimental EAE models (grey versus white matter), might provide additional, clinically relevant insights into the role of MCU as a therapeutic target for treating autoimmunity. This evidence concerns the gene MCU and Autoimmunity.